• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Direxion Daily S&P Biotech Bull 3X ETF (NY:LABU)

146.14 -11.33 (-7.20%)
Official Closing Price Updated: 8:00 PM EDT, Mar 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 846,153
Open 154.91
Bid (Size) 145.09 (500)
Ask (Size) 146.50 (200)
Prev. Close 157.47
Today's Range 145.74 - 154.91
52wk Range 32.55 - 198.18
Shares Outstanding 102,744
Dividend Yield 2.49%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗
March 10, 2026
H.C. Wainwright stated that the reported departure of a key U.S. Food and Drug Administration official at the end of April bodes well for uniQure. 
Via Stocktwits
Topics Initial Public Offering
News headline image
Why Did QURE Stock Almost Halve Pre-Market Today? ↗
March 02, 2026
uniQure said the FDA does not agree that Phase I/II data are sufficient to serve as primary evidence of effectiveness for a marketing application for its Huntington’s disease gene therapy, AMT-130. 
Via Stocktwits

Performance

YTD
-7.2%
-7.2%
1 Month
-9.8%
-9.8%
3 Month
-6.6%
-6.6%
6 Month
+88.2%
+88.2%
1 Year
+96.8%
+96.8%

More News

Read More
News headline image
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗
November 27, 2025
Via Stocktwits
Topics ETFs
SNDX Stock Is The Talk Of The Town Today: Here’s Everything To Know About The Latest FDA Approval ↗
October 24, 2025
Via Stocktwits
News headline image
Sector Rotation ↗
January 08, 2022
Via Talk Markets
News headline image
Can These 5 Assets Skyrocket Your Portfolio? ↗
September 22, 2024
Via Talk Markets
Topics ETFs Stocks
News headline image
EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks ↗
August 30, 2024
Via Benzinga
News headline image
Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win ↗
June 06, 2024
Via Talk Markets
Topics ETFs Stocks
News headline image
The 3 Best Leveraged ETFs for April 2024 ↗
April 02, 2024
Via InvestorPlace
Topics ETFs
News headline image
5 Best-Performing Leveraged ETFs Of February ↗
March 02, 2024
Via Talk Markets
Topics ETFs Stocks
News headline image
Stocks To Watch This Week - Sunday, Feb. 11 ↗
February 11, 2024
Via Talk Markets
Topics ETFs
News headline image
Want Diversified Upside in Biotechnology? Check out LABU
March 22, 2023
Via MarketBeat
Topics ETFs Stocks
News headline image
The Week Ahead Commentary - Saturday, Feb. 4 ↗
February 05, 2023
Via Talk Markets
News headline image
J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps ↗
January 17, 2023
Via Talk Markets
News headline image
3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty ↗
February 22, 2022
Via InvestorPlace
News headline image
The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)… ↗
February 11, 2022
Via Talk Markets
News headline image
3 Biotech Stocks to Buy That Are Under Severe Pressure ↗
January 13, 2022
Via InvestorPlace
News headline image
5 Best Leveraged ETFs of Last Week ↗
December 28, 2021
Via Talk Markets
News headline image
5 Best-Performing Leveraged ETFs of August ↗
September 01, 2021
Via Talk Markets
News headline image
The Week In Charts: Figure This Out And You’ll Own The World ↗
August 07, 2021
Via Talk Markets
News headline image
The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs ↗
July 31, 2021
Via Talk Markets
News headline image
The Week In Charts: Trading Stuff Part 2-IPOs, ETFs, And, The Secret To Trading ↗
July 23, 2021
Via Talk Markets
News headline image
These Were The Stocks David Green Discussed On His Show This Morning ↗
July 06, 2021
Via Benzinga
News headline image
The Week In Charts-Volatility: Rabbit Hole Or Holy Grail? ↗
June 11, 2021
Via Talk Markets
News headline image
A Biotech ETF For Aggressive, Risk-Tolerant Investors ↗
June 08, 2021
Via Talk Markets
Topics Stocks

Frequently Asked Questions

Is Direxion Daily S&P Biotech Bull 3X ETF publicly traded?
Yes, Direxion Daily S&P Biotech Bull 3X ETF is publicly traded.
What exchange does Direxion Daily S&P Biotech Bull 3X ETF trade on?
Direxion Daily S&P Biotech Bull 3X ETF trades on the New York Stock Exchange
What is the ticker symbol for Direxion Daily S&P Biotech Bull 3X ETF?
The ticker symbol for Direxion Daily S&P Biotech Bull 3X ETF is LABU on the New York Stock Exchange
What is the current price of Direxion Daily S&P Biotech Bull 3X ETF?
The current price of Direxion Daily S&P Biotech Bull 3X ETF is 146.14
When was Direxion Daily S&P Biotech Bull 3X ETF last traded?
The last trade of Direxion Daily S&P Biotech Bull 3X ETF was at 03/18/26 08:00 PM ET
What is the market capitalization of Direxion Daily S&P Biotech Bull 3X ETF?
The market capitalization of Direxion Daily S&P Biotech Bull 3X ETF is 15.02M
How many shares of Direxion Daily S&P Biotech Bull 3X ETF are outstanding?
Direxion Daily S&P Biotech Bull 3X ETF has 15M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap